PMID- 37994240 OWN - NLM STAT- MEDLINE DCOM- 20240104 LR - 20250626 IS - 1522-726X (Electronic) IS - 1522-1946 (Print) IS - 1522-1946 (Linking) VI - 103 IP - 1 DP - 2024 Jan TI - Computed tomography derived anatomical predictors of vascular access complications following transfemoral transcatheter aortic valve implantation: A systematic review. PG - 169-185 LID - 10.1002/ccd.30918 [doi] AB - BACKGROUND: Vascular complications after percutaneous transfemoral transcatheter aortic valve implantation (TAVI) are associated with adverse clinical outcomes and remain a significant challenge. AIMS: The purpose of this review is to synthesize the existing evidence regarding the iliofemoral artery features predictive of vascular complications after TAVI on pre-procedural contrast-enhanced multidetector computed tomography (MDCT). METHODS: A systematic search was performed in Embase and Medline (Pubmed) databases. Studies of patients undergoing transfemoral TAVI with MDCT were included. Studies with only valve-in-valve TAVI, planned surgical intervention and those using fluoroscopic assessment were excluded. Data on study cohort, procedural characteristics and significant predictors of vascular complications were extracted. RESULTS: We identified 23 original studies involving 8697 patients who underwent TAVI between 2006 and 2020. Of all patients, 8514 (97.9%) underwent percutaneous transfemoral-TAVI, of which 8068 (94.8%) had contrast-enhanced MDCT. The incidence of major vascular complications was 6.7 +/- 4.1% and minor vascular complications 26.1 +/- 7.8%. Significant independent predictors of major and minor complications related to vessel dimensions were common femoral artery depth (>54 mm), sheath-to-iliofemoral artery diameter ratio (>0.91-1.19), sheath-to-femoral artery diameter ratio (>1.03-1.45) and sheath-to-femoral artery area ratio (>1.35). Substantial iliofemoral vessel tortuosity predicted 2-5-fold higher vascular risk. Significant iliofemoral calcification predicted 2-5-fold higher risk. The iliac morphology score was the only hybrid scoring system with predictive value. CONCLUSIONS: Independent iliofemoral predictors of access-site complications in TAVI were related to vessel size, depth, calcification and tortuosity. These should be considered when planning transfemoral TAVI and in the design of future risk prediction models. CI - (c) 2023 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals LLC. FAU - Androshchuk, Vitaliy AU - Androshchuk V AUID- ORCID: 0000-0002-1464-3109 AD - School of Cardiovascular Medicine & Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK. AD - Department of Cardiology, St Thomas' Hospital, King's College London, London, UK. FAU - Chehab, Omar AU - Chehab O AD - School of Cardiovascular Medicine & Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK. AD - Department of Cardiology, St Thomas' Hospital, King's College London, London, UK. FAU - Prendergast, Bernard AU - Prendergast B AD - Department of Cardiology, St Thomas' Hospital, King's College London, London, UK. FAU - Rajani, Ronak AU - Rajani R AD - Department of Cardiology, St Thomas' Hospital, King's College London, London, UK. AD - School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK. FAU - Patterson, Tiffany AU - Patterson T AD - School of Cardiovascular Medicine & Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK. AD - Department of Cardiology, St Thomas' Hospital, King's College London, London, UK. FAU - Redwood, Simon AU - Redwood S AD - School of Cardiovascular Medicine & Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK. AD - Department of Cardiology, St Thomas' Hospital, King's College London, London, UK. LA - eng GR - FS/14/11/30526/BHF_/British Heart Foundation/United Kingdom GR - FS/CRTF/22/24328/BHF_/British Heart Foundation/United Kingdom PT - Journal Article PT - Systematic Review DEP - 20231122 PL - United States TA - Catheter Cardiovasc Interv JT - Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions JID - 100884139 SB - IM MH - Humans MH - Aortic Valve/diagnostic imaging/surgery MH - *Aortic Valve Stenosis/diagnostic imaging/surgery/complications MH - Femoral Artery/diagnostic imaging/surgery MH - Tomography, X-Ray Computed/methods MH - *Transcatheter Aortic Valve Replacement/adverse effects/methods MH - Treatment Outcome MH - *Vascular Diseases/complications PMC - PMC10915898 OTO - NOTNLM OT - AVDP - aortic valve disease OT - ICT - imaging OT - VCOM - vascular complications OT - electron beam CT/multidetector CT OT - percutaneous intervention COIS- The authors declare no conflicts of interest. EDAT- 2023/11/23 06:42 MHDA- 2024/01/04 11:44 PMCR- 2024/03/06 CRDT- 2023/11/23 04:03 PHST- 2023/10/17 00:00 [revised] PHST- 2023/08/15 00:00 [received] PHST- 2023/11/12 00:00 [accepted] PHST- 2024/01/04 11:44 [medline] PHST- 2023/11/23 06:42 [pubmed] PHST- 2023/11/23 04:03 [entrez] PHST- 2024/03/06 00:00 [pmc-release] AID - CCD30918 [pii] AID - 10.1002/ccd.30918 [doi] PST - ppublish SO - Catheter Cardiovasc Interv. 2024 Jan;103(1):169-185. doi: 10.1002/ccd.30918. Epub 2023 Nov 22. PMID- 35935394 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220809 IS - 2514-2119 (Electronic) IS - 2514-2119 (Linking) VI - 6 IP - 8 DP - 2022 Aug TI - Small vessel vasculitis associated with culture-negative infective endocarditis related to a cardiac device: a case report. PG - ytac294 LID - 10.1093/ehjcr/ytac294 [doi] LID - ytac294 AB - BACKGROUND: Culture-negative endocarditis is uncommon, occurring in less than a third of all cases of infective endocarditis (IE). Culture-negative IE related to a cardiac device is an even greater diagnostic challenge due to its insidious presentation, with onset of symptoms ranging between 3 and 12 months after device implantation. Sensitivity of the modified Duke's criteria remains low in culture-negative and cardiac device-related IE (CDRIE) since classical signs and symptoms of IE are often absent. Small vessel vasculitis has been reported as an immune response to IE. Recognizing immunological phenomenon related to IE is of paramount clinical importance, prompting the search for an underlying infection and avoiding the use of immunosuppressive medications which would otherwise result in an adverse outcome. CASE SUMMARY: An 81-year-old Caucasian male presented to the ambulatory medical unit with a two-week history of a symmetrical, generalized purpuric rash. He had an indwelling permanent pacemaker following a transcatheter aortic valve implantation for severe aortic stenosis five years ago. Blood tests showed an iron deficiency anaemia, thrombocytopenia and normal renal function, both CRP and ESR were raised at 61 and 30 mm/hr, respectively. Skin biopsy demonstrated small vessel cutaneous vasculitis. Transthoracic echocardiography revealed a mobile mass measuring 0.9 x 1.7 cm, confirmed on transoesophageal echocardiogram as pacing lead endocarditis. Blood cultures were persistently negative. The patient underwent pacemaker lead extraction, following which the vasculitic rash improved. DISCUSSION: Blood cultures in IE are more likely to be negative if there is a prior antibiotic administration or causative micro-organisms with limited proliferation which fail to grow in conventional media conditions. Transesophageal echocardiography (TOE) offers improved sensitivity and diagnostic yield when compared to transthoracic echocardiography (TTE) in patients with a high clinical suspicion of CDRIE. The evidence in the literature describing culture-negative IE associated with small vessel vasculitis is limited. However, it is recognized that cutaneous small vessel vasculitis may be associated with an underlying bacterial infection. IE produces an inflammatory response, resulting in the deposition of circulating immune complexes and cutaneous signs which are included in the modified Duke's criteria to aid diagnosis. Management of CDRIE requires a multi-disciplinary team approach with an 'Endocarditis Team.' Pacemaker lead infection requires transvenous lead extraction if it is a newly implanted lead. Locking stylets, extraction sheaths or snare retrieval are usually required in cases of older implanted leads. Surgical lead extraction remains the gold standard for larger vegetations (>20 mm) or associated valve endocarditis. CI - (c) The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. FAU - El-Gaaly, Maged AU - El-Gaaly M AD - Cardiology Department, Leeds Teaching Hospitals NHS Trust, Leeds, LS9 7, UK. FAU - Tomlinson, James Steven AU - Tomlinson JS AUID- ORCID: 0000-0002-8815-0518 AD - Cardiology Department, North Bristol NHS Trust, Southmead Hospital, Southmead Road, Westbury-On-Trym, Bristol BS10 5NB, UK. FAU - Ezzo, Talal AU - Ezzo T AD - Cardiology Department, Calderdale and Huddersfield NHS Foundation Trust, Halifax, HD3 3EA, UK. LA - eng PT - Case Reports PT - Journal Article DEP - 20220802 PL - England TA - Eur Heart J Case Rep JT - European heart journal. Case reports JID - 101730741 PMC - PMC9351725 OTO - NOTNLM OT - Case report OT - Cutaneous small vessel vasculitis OT - Infective endocarditis OT - Permanent pacemaker OT - Transesophageal echocardiography OT - Transthoracic echocardiography EDAT- 2022/08/09 06:00 MHDA- 2022/08/09 06:01 PMCR- 2022/08/02 CRDT- 2022/08/08 03:31 PHST- 2021/08/09 00:00 [received] PHST- 2021/09/14 00:00 [revised] PHST- 2022/07/13 00:00 [accepted] PHST- 2022/08/08 03:31 [entrez] PHST- 2022/08/09 06:00 [pubmed] PHST- 2022/08/09 06:01 [medline] PHST- 2022/08/02 00:00 [pmc-release] AID - ytac294 [pii] AID - 10.1093/ehjcr/ytac294 [doi] PST - epublish SO - Eur Heart J Case Rep. 2022 Aug 2;6(8):ytac294. doi: 10.1093/ehjcr/ytac294. eCollection 2022 Aug. PMID- 32773221 OWN - NLM STAT- MEDLINE DCOM- 20201110 LR - 20201110 IS - 1879-1913 (Electronic) IS - 0002-9149 (Linking) VI - 132 DP - 2020 Oct 1 TI - Meta-analysis of Incidence, Predictors and Consequences of Clinical and Subclinical Bioprosthetic Leaflet Thrombosis After Transcatheter Aortic Valve Implantation. PG - 106-113 LID - S0002-9149(20)30689-5 [pii] LID - 10.1016/j.amjcard.2020.07.018 [doi] AB - Leaflet thrombosis (LT) has been claimed as a potential cause of hemodynamic dysfunction or bioprosthetic valve degeneration of transcatheter heart valves. Sparse and contrasting evidence exists, however, regarding LT occurrence, prevention and treatment. MEDLINE, ISI Web of Science and SCOPUS databases were searched for studies published up to January 2020. Only studies reporting data on incidence and outcomes associated to the presence/absence of clinical or subclinical LT, detected or confirmed with a multidetector computed tomography exam were included. The study was designed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) requirements. Two reviewers independently screened articles for fulfillment of inclusion criteria. Data were pooled using a random-effect model. The primary end point was the incidence of LT. Secondary outcomes included: stroke and transient ischemic attacks and mean transvalvular gradients at different time-points in patients with and without LT. Of the initial 200 studies, 22 were finally included with a total of 11,567 patients. LT overall incidence was 8% (95% Confidence Interval [CI]: 5% to 13%, I(2) = 96.4%). LT incidence in patients receiving only antiplatelets was 13% (95% CI: 7% to 23%, p <0.0001); patients discharged on oral anticoagulants had a reported incidence of 4% (95% CI: 2% to 8%, p <0.0001). Patients with LT, either clinical or subclinical, were not at increased risk of stroke (OR 1.06, 95% CI: 0.75 to 1.50, p = 0.730, I(2) = 0.0%) or transient ischemic attacks (Odds Ratio 1.01, 95% CI: 0.40 to 2.57, p = 0.989, I(2) = 0.0%). LT was associated with higher mean transvalvular gradients compared with patients without LT at 30 days post-transcatheter implantation, but not at discharge or at 1 year. LT is a relatively common event that, even when clinically manifest, is not associated with an increased risk of cerebrovascular events. Although patients on anticoagulants appear to be at lower risk of LT, the available evidence does not allow formulation of recommendations for prophylactical anticoagulation nor routine computed tomography after transcatheter aortic valve replacement. CI - Copyright (c) 2020 Elsevier Inc. All rights reserved. FAU - Sannino, Anna AU - Sannino A AD - The Heart Hospital, Clinical Research Department, Baylor Scott & White Research Institute, Plano, Texas; Department of Advance Biomedical Sciences, University Federico II, Naples, Italy. FAU - Hahn, Rebecca T AU - Hahn RT AD - New York Presbyterian Hospital, New York-Presbyterian/Columbia University Medical Center, New York, New York. FAU - Leipsic, Jonathon AU - Leipsic J AD - Department of Radiology, St. Paul's Hospital, University of British Columbia, Vancouver, Canada. FAU - Mack, Michael J AU - Mack MJ AD - The Heart Hospital Baylor Plano, Plano, Texas. FAU - Grayburn, Paul A AU - Grayburn PA AD - The Heart Hospital, Clinical Research Department, Baylor Scott & White Research Institute, Plano, Texas; The Heart Hospital Baylor Plano, Plano, Texas. Electronic address: paul.grayburn@BSWHealth.org. LA - eng PT - Journal Article PT - Meta-Analysis PT - Review DEP - 20200713 PL - United States TA - Am J Cardiol JT - The American journal of cardiology JID - 0207277 SB - IM MH - Aortic Valve Stenosis/surgery MH - Bioprosthesis/*adverse effects MH - Global Health MH - Heart Diseases/*epidemiology/etiology MH - Humans MH - Incidence MH - Postoperative Complications/*epidemiology/etiology MH - *Registries MH - Risk Factors MH - Thrombosis/*epidemiology/etiology MH - Transcatheter Aortic Valve Replacement/*adverse effects EDAT- 2020/08/11 06:00 MHDA- 2020/11/11 06:00 CRDT- 2020/08/11 06:00 PHST- 2020/06/22 00:00 [received] PHST- 2020/07/02 00:00 [revised] PHST- 2020/07/03 00:00 [accepted] PHST- 2020/08/11 06:00 [pubmed] PHST- 2020/11/11 06:00 [medline] PHST- 2020/08/11 06:00 [entrez] AID - S0002-9149(20)30689-5 [pii] AID - 10.1016/j.amjcard.2020.07.018 [doi] PST - ppublish SO - Am J Cardiol. 2020 Oct 1;132:106-113. doi: 10.1016/j.amjcard.2020.07.018. Epub 2020 Jul 13. PMID- 31957895 OWN - NLM STAT- MEDLINE DCOM- 20210423 LR - 20210423 IS - 1932-8737 (Electronic) IS - 0160-9289 (Print) IS - 0160-9289 (Linking) VI - 43 IP - 5 DP - 2020 May TI - Impact of leaflet thrombosis on hemodynamics and clinical outcomes after bioprosthetic aortic valve replacement: A meta-analysis. PG - 468-474 LID - 10.1002/clc.23331 [doi] AB - BACKGROUND: Leaflet thrombosis (LT, also called cusp thrombosis) detected by multidetector computed tomography (MDCT) is common in bioprosthetic aortic valve replacement (bAVR). However, it remains contradictory whether MDCT-defined LT following bAVR is associated with hemodynamic deterioration and stroke. Thus, we performed the first meta-analysis to assess hemodynamic outcomes and updated the latest researches on the clinical outcomes of MDCT-defined LT after bAVR. HYPOTHESIS: MDCT-defined LT might be associated with worse hemodynamic and clinical outcomes after bAVR. METHOD: MEDLINE, EMBASE, Cochrane Library, and ClinicalTrial.gov were searched from inception to 15th April 2019. The fix-effect model was utilized to calculate odds ratio (OR) and 95% confidence interval (CI). The primary outcomes were hemodynamic stability indexes, including mean pressure gradient (MPG), left ventricular ejection fraction (LVEF), paravalvular leak (PVL), and clinical heart failure. The secondary endpoints were major adverse cardiovascular and cerebrovascular events (MACCEs), which consisted of myocardial infarction, all-cause death, stroke, and transient ischemic attack (TIA). RESULTS: Twelve studies with 4820 patients were included. The total prevalence of MDCT-defined LT was 9.7%. MDCT-defined LT was associated with a significantly increased risk of MPG (inverse variance 0.43, 95% CI: [0.30, 0.57]), MACCEs (OR 2.43, 95% CI: [1.45, 4.06]), stroke (OR 1.79, 95% CI: [1.03, 3.11]), and TIA (OR 4.09, 95% CI: [1.59, 10.54]). There were no differences for other outcomes. CONCLUSIONS: MDCT-defined LT after bAVR is associated with increased MPG and increased risk of adverse cerebrovascular events, including TIA and stroke. While LVEF, PVL, and clinical heart failure were similar between patient with and without LT. CI - (c) 2020 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc. FAU - Tian, Zixin AU - Tian Z AD - Department of Cardiology, Shengjing Hospital of China Medical University, Shengyang, Liaoning Province, People's Republic of China. FAU - Li, Tiejun AU - Li T AD - Department of Cardiology, Shengjing Hospital of China Medical University, Shengyang, Liaoning Province, People's Republic of China. FAU - Ma, Shumei AU - Ma S AUID- ORCID: 0000-0001-5546-0029 AD - Department of Cardiology, Shengjing Hospital of China Medical University, Shengyang, Liaoning Province, People's Republic of China. LA - eng PT - Journal Article DEP - 20200120 PL - United States TA - Clin Cardiol JT - Clinical cardiology JID - 7903272 SB - IM MH - Aged MH - Aged, 80 and over MH - Aortic Valve/pathology/*surgery MH - Bioprosthesis/adverse effects/*statistics & numerical data MH - Coronary Thrombosis/*diagnosis/etiology MH - Female MH - Heart Valve Prosthesis/adverse effects/*statistics & numerical data MH - Hemodynamics MH - Humans MH - Male MH - Multidetector Computed Tomography/*statistics & numerical data MH - Stroke Volume MH - Transcatheter Aortic Valve Replacement/*adverse effects/statistics & numerical data MH - Treatment Outcome MH - Ventricular Function, Left PMC - PMC7244303 OTO - NOTNLM OT - aortic stenosis OT - bioprosthetic aortic valve OT - surgical aortic valve replacement OT - thrombosis OT - transcatheter aortic valve replacement EDAT- 2020/01/21 06:00 MHDA- 2021/04/24 06:00 PMCR- 2020/01/20 CRDT- 2020/01/21 06:00 PHST- 2019/10/11 00:00 [received] PHST- 2019/12/05 00:00 [revised] PHST- 2020/01/02 00:00 [accepted] PHST- 2020/01/21 06:00 [pubmed] PHST- 2021/04/24 06:00 [medline] PHST- 2020/01/21 06:00 [entrez] PHST- 2020/01/20 00:00 [pmc-release] AID - CLC23331 [pii] AID - 10.1002/clc.23331 [doi] PST - ppublish SO - Clin Cardiol. 2020 May;43(5):468-474. doi: 10.1002/clc.23331. Epub 2020 Jan 20. PMID- 29235436 OWN - NLM STAT- MEDLINE DCOM- 20190409 LR - 20210705 IS - 1969-6213 (Electronic) IS - 1774-024X (Linking) VI - 13 IP - 15 DP - 2018 Feb 2 TI - Bioprosthetic aortic valve leaflet thrombosis detected by multidetector computed tomography is associated with adverse cerebrovascular events: a meta-analysis of observational studies. PG - e1748-e1755 LID - EIJ-D-17-01062 [pii] LID - 10.4244/EIJ-D-17-01062 [doi] AB - AIMS: Leaflet thrombosis (LT) has become increasingly recognised following transcatheter and surgical aortic bioprosthetic valve (ABV) replacement and can be reliably identified by multidetector computed tomography (MDCT). However, it is an ongoing debate whether MDCT-defined LT is associated with adverse cerebrovascular outcomes. We sought to perform a systematic review and meta-analysis in order to assess the incidence and clinical outcomes associated with MDCT-defined leaflet thrombosis following (ABV) replacement. METHODS AND RESULTS: Electronic databases were searched for studies that performed mandatory MDCT imaging following ABV replacement. The primary endpoint was the incidence of cerebrovascular events, defined as a composite of stroke or transient ischaemic attack (TIA). Secondary endpoints included major adverse cerebrovascular and cardiovascular events (MACCE), stroke, TIA, death or myocardial infarction. In total, six studies met the inclusion criteria with 11.6% (198/1,704) of patients having MDCT-defined LT. The prevalence of LT following transcatheter and surgical ABV replacement was 13.2% and 3.6%, respectively. Cerebrovascular events were significantly increased in patients with LT (odds ratio [OR] 3.38, 95% CI: 1.78-6.41, p<0.001). The risk of MACCE (OR 2.10, 95% CI: 1.21-3.64, p<0.001) and TIA (OR 5.86, 95% CI: 2.05-16.75, p<0.001) was also increased in patients with LT, although there were no differences in the incidence of stroke (OR 2.43, 95% CI: 1.00-5.93, p=0.05), death (OR 0.92, 95% CI: 0.42-2.03, p=0.84) or myocardial infarction (OR 1.72, 95% CI: 0.34-9.78, p=0.54) between groups. CONCLUSIONS: MDCT-defined LT following ABV replacement is associated with a significantly increased risk of adverse cerebrovascular events. Further prospective studies are required to ascertain whether LT can be prevented or treated with pharmacological strategies. FAU - Rashid, Hashrul N AU - Rashid HN AD - Monash Cardiovascular Research Centre, Monash University and MonashHeart, Monash Health, Clayton, Victoria, Australia. FAU - Gooley, Robert P AU - Gooley RP FAU - Nerlekar, Nitesh AU - Nerlekar N FAU - Ihdayhid, Abdul R AU - Ihdayhid AR FAU - McCormick, Liam M AU - McCormick LM FAU - Nasis, Arthur AU - Nasis A FAU - Cameron, James D AU - Cameron JD FAU - Brown, Adam J AU - Brown AJ LA - eng PT - Journal Article PT - Meta-Analysis PT - Systematic Review DEP - 20180202 PL - France TA - EuroIntervention JT - EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology JID - 101251040 SB - IM CIN - EuroIntervention. 2018 Feb 02;13(15):e1738-e1740. doi: 10.4244/EIJV13I15A281. PMID: 29400278 MH - Aged MH - Aged, 80 and over MH - Aortic Valve/diagnostic imaging/physiopathology/*surgery MH - Aortic Valve Stenosis/diagnostic imaging/mortality/physiopathology/*surgery MH - *Bioprosthesis MH - Cerebrovascular Disorders/diagnostic imaging/etiology MH - Female MH - *Heart Valve Prosthesis MH - Heart Valve Prosthesis Implantation/*adverse effects/*instrumentation/mortality MH - Humans MH - Male MH - *Multidetector Computed Tomography MH - Predictive Value of Tests MH - Prosthesis Design MH - Risk Assessment MH - Risk Factors MH - Thrombosis/*diagnostic imaging/etiology/mortality MH - Transcatheter Aortic Valve Replacement/adverse effects/instrumentation/mortality MH - Treatment Outcome EDAT- 2017/12/14 06:00 MHDA- 2019/04/10 06:00 CRDT- 2017/12/14 06:00 PHST- 2017/12/14 06:00 [pubmed] PHST- 2019/04/10 06:00 [medline] PHST- 2017/12/14 06:00 [entrez] AID - EIJ-D-17-01062 [pii] AID - 10.4244/EIJ-D-17-01062 [doi] PST - epublish SO - EuroIntervention. 2018 Feb 2;13(15):e1748-e1755. doi: 10.4244/EIJ-D-17-01062. PMID- 24121948 OWN - NLM STAT- MEDLINE DCOM- 20140117 LR - 20131014 IS - 0034-1193 (Print) IS - 0034-1193 (Linking) VI - 104 IP - 9 DP - 2013 Sep TI - [Role of multimodality imaging in patients undergoing transcatheter aortic valve implantation]. PG - 498-505 LID - 10.1701/1331.14739 [doi] AB - Aortic stenosis is a common disorder. Aortic valve replacement is indicated for symptomatic patients with severe aortic stenosis, as the prognosis of untreated patients is poor. However, despite aortic valve replacement can produce dramatic benefit in the setting of aortic stenosis, morbidity and mortality associated with surgery has fostered a search for alternatives. Transcatheter aortic valve replacement is a novel method to treat selected high-risk patients with aortic stenosis. Patient screening and anatomic measurements of the aortic root, aortic cusp heights, and the distance between aortic annulus and coronary ostia, as well as the evaluation of coronary arteries and peripheral arterial disease are of great importance to ensure procedural success . This review outlines the evolving role of non-invasive multimodality imaging, including echocardiography, multidetector computed tomography and cardiac magnetic resonance, in support of transcatheter aortic valve implantation, and describes how the multimodality imaging approach is crucial in this clinical setting. FAU - Bertella, Erika AU - Bertella E FAU - Mushtaq, Saima AU - Mushtaq S FAU - Andreini, Daniele AU - Andreini D FAU - Pontone, Gianluca AU - Pontone G LA - ita PT - English Abstract PT - Journal Article PT - Review TT - Ruolo dell'imaging multimodale nei pazienti candidati ad impianto di valvola aortica percutanea. PL - Italy TA - Recenti Prog Med JT - Recenti progressi in medicina JID - 0401271 SB - IM MH - Algorithms MH - Aortic Valve Stenosis/*diagnosis/surgery/*therapy MH - *Cardiac Catheterization MH - *Echocardiography/methods MH - *Heart Valve Prosthesis Implantation/methods MH - Humans MH - *Magnetic Resonance Imaging, Cine/methods MH - *Multidetector Computed Tomography/methods MH - Treatment Outcome EDAT- 2013/10/15 06:00 MHDA- 2014/01/18 06:00 CRDT- 2013/10/15 06:00 PHST- 2013/10/15 06:00 [entrez] PHST- 2013/10/15 06:00 [pubmed] PHST- 2014/01/18 06:00 [medline] AID - 10.1701/1331.14739 [doi] PST - ppublish SO - Recenti Prog Med. 2013 Sep;104(9):498-505. doi: 10.1701/1331.14739.